Clinical Trials Browser

Stomach Neoplasms × olaparib × 30 days × Clear all

NCT05379972 2026-06-05

Study of SBRT/Olaparib Followed by Pembrolizumab/Olaparib in Gastric Cancers

Phase 2 Completed

9 enrolled 8 charts

Gastrointestinal

Stomach Neoplasms